Using lysosomal and proteasomal degradation inhibitors, we observed that NFATc1 induces lysosomal degradation of Orai3 in both invasive and metastatic pancreatic cancer cells (Fig. 4A–D). Here, ORAI3 is linked to pancreatic neoplasm.